<DOC>
	<DOC>NCT00141362</DOC>
	<brief_summary>Evaluate long-term safety and efficacy of pregabalin in patients with chronic neuropathic pain.</brief_summary>
	<brief_title>Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Chronic Neuropathic Pain.</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Must have met the inclusion criteria for the preceding doubleblind BID study in diabetic neuropathy or postherpetic neuralgia. Must have received study medication under doubleblind conditions. Patients cannot participate if they experienced a serious adverse event during the previous doubleblind BID study which was determined to be related to the study medication.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2006</verification_date>
</DOC>